Microba Life Sciences Limited (MAP.AX)
AUD 0.19
(0.0%)
AUD 0.19
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 | -0.05 AUD | -27.56% |
| 2023 | -0.04 AUD | 3.54% |
| 2022 | -0.04 AUD | -52.51% |
| 2021 | -0.03 AUD | -13.1% |
| 2020 | -0.02 AUD | -40.49% |
| 2019 | -0.02 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.03 AUD | -99.35% |
| 2024 FY | - AUD | -27.56% |
| 2024 Q1 | -0.02 AUD | 19.27% |
| 2024 Q4 | -0.02 AUD | 0.0% |
| 2023 Q1 | -0.01 AUD | 47.06% |
| 2023 Q4 | -0.02 AUD | -86.41% |
| 2023 FY | - AUD | 3.54% |
| 2023 Q3 | -0.01 AUD | 44.92% |
| 2023 Q2 | -0.02 AUD | -88.89% |
| 2022 Q1 | -0.02 AUD | -2.72% |
| 2022 Q4 | -0.02 AUD | -96.84% |
| 2022 FY | - AUD | -52.51% |
| 2022 Q3 | -0.01 AUD | 54.11% |
| 2022 Q2 | -0.02 AUD | -9.52% |
| 2021 Q3 | -0.01 AUD | -74.67% |
| 2021 FY | - AUD | -13.1% |
| 2021 Q4 | -0.02 AUD | -40.46% |
| 2021 Q2 | -0.01 AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2020 FY | - AUD | -40.49% |
| 2019 FY | - AUD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Australian Clinical Labs Limited | 0.12 AUD | 140.5% |
| BCAL Diagnostics Limited | -0.03 AUD | -86.923% |
| Genetic Signatures Limited | -0.11 AUD | 55.818% |
| Genetic Technologies Limited | -0.09 AUD | 46.535% |
| Healius Limited | -0.98 AUD | 95.041% |
| Imagion Biosystems Limited | -0.41 AUD | 88.146% |
| Integral Diagnostics Limited | -0.26 AUD | 81.308% |
| INOVIQ Ltd | -0.07 AUD | 31.453% |
| Monash IVF Group Limited | -0.02 AUD | -189.286% |
| Rhythm Biosciences Limited | -0.03 AUD | -62.0% |
| Sonic Healthcare Limited | 1.07 AUD | 104.542% |